LDHA and cancer: Aldehyde dehydrogenase (ALDH) inhibitor disulfiram was among four cancer selective inhibitors identified blocking the growth of cultured TMPRSS2-ERG fusion positive VCaP cells at nanomolar concentration as well as reducing VCaP xenograft growth in vivo[2].